Other OTC - Delayed Quote USD

Tryp Therapeutics Inc. (TRYPF)

0.0490 +0.0020 (+4.26%)
At close: April 26 at 3:32 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for TRYPF

Recent News: TRYPF

View More
Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt

Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt
ACCESSWIRE 4 days ago
Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order

Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
ACCESSWIRE last month
Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting

Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting
ACCESSWIRE 2 months ago
Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX

Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
ACCESSWIRE 3 months ago
Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)
ACCESSWIRE 3 months ago
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan

Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
ACCESSWIRE 3 months ago
Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited

Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
ACCESSWIRE 4 months ago
Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
ACCESSWIRE 5 months ago
Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million

Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
ACCESSWIRE 5 months ago
Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000

Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
ACCESSWIRE 6 months ago
Tryp Therapeutics Announces Private Placement of Unsecured Convertible Debentures for Gross Proceeds of up to AUD$175,000

Tryp Therapeutics Announces Private Placement of Unsecured Convertible Debentures for Gross Proceeds of up to AUD$175,000
ACCESSWIRE 6 months ago
Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer

Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
ACCESSWIRE 8 months ago
View More

Related Tickers

J4T.SG Blue Water Vaccines Inc
0.1070
+2.88%
 
ILA.AX Island Pharmaceuticals Limited
0.0530
0.00%
 
BETRF BetterLife Pharma Inc.
0.0765
+6.45%
 
AWKNF Awakn Life Sciences Corp.
0.1350
-1.72%
 
NBIO Nascent Biotech, Inc.
0.0999
0.00%
 
NMLSF Nova Mentis Life Science Corp.
0.0115
0.00%
 
MESC.CN Lophos Holdings Inc.
0.0500
-16.67%
 
RAC.AX Race Oncology Limited
1.3100
+1.55%
 
MDXXF Pharmala Biotech Holdings Inc.
0.1611
+1.95%
 
BVAXF BioVaxys Technology Corp.
0.0625
0.00%